Tonsils - tonsillar neoplasms

Key points
- Cancers of the tonsil tend to be superficial, better differentiated, and of an earlier stage than other oropharyngeal tumors.
- Radiation for early cancers offers the advantage of treating upper-echelon lymph nodes.
- Radical radiotherapy to lymph nodes controls approximately 90% of limited nodal disease (N1) if the primary tumor is controlled, but nodal failure increases to more than 20% if failure occurs at the primary tumor site.
- The treatment of early tonsillar neoplasms (stages I and II) is usually radiation therapy alone.
Cancers of the tonsil tend to be superficial, better differentiated, and of an earlier stage than other oropharyngeal tumors. The treatment of early tonsillar neoplasms (stages I and II) is usually radiation therapy alone. Transoral wide local excision of small, superficial lesions may be locally effective, but does not address the high potential of occult lymph node metastasis. Deeply invasive cancers require extensive resections of the pharyngeal wall or mandible.
Radiation for early cancers offers the advantage of treating upper-echelon lymph nodes. Treatment is usually unilateral unless extension to the tongue base or midline soft palate is present that warrants treatment of contralateral lymphatics. Ipsilateral treatment portals allow sparing of the contralateral mucosa and salivary glands. Because much of the tumor may be hidden from external beam photons by the mandible, deeper dose calculation with electron beam therapy is used, which can be combined with a small interstitial implant if invasion of adjacent tongue is present. Early cancers of the tonsillar pillar are less effectively treated with radiation alone than are cancers confined to the tonsillar fossa.
Radical radiotherapy to lymph nodes controls approximately 90% of limited nodal disease (N1) if the primary tumor is controlled, but nodal failure increases to more than 20% if failure occurs at the primary tumor site. Overall 5-year survival rates for patients with advanced primary tumors or regional metastases are generally less than 25% with single-modality therapy. Combinations of surgery and radiation therapy offer improved rates of local and regional tumor control, which, in some studies, has translated into improved survival. Similar tumor-control and survival rates have been reported for stage III (T3N0) patients without nodal metastases who are treated with radiation alone or combined surgery and radiation or surgery alone (Table 90-9). In general, preoperative or postoperative radiation for advanced (stage III or IV) cancers of the tonsillar fossa is recommended, combined with resection to include the tonsillar fossa and regional nodes. In some instances, advances in surgical approaches may allow for sparing of the mandible, but composite resection of the pharynx, mandible, and neck remains a frequent surgical approach. Postoperative rather than preoperative radiation is currently preferred because it allows more accurate assessment of surgical margins, local extent of disease, and degree of lymphatic involvement, and is associated with lower rates of surgical complications.
Next article Tongue-base tumors » »
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsStudy shows broccoli may offer protection against liver cancer
Consumption of broccoli has increased in the United States over the last few decades as scientists have reported that eating the vegetable three to five times per week can lower the risk of many types of cancer…
4 March 2016
NewsNovel gene variants identified in male breast cancer
Male breast cancer (MBC) is a very rare tumor type, occurring in just 1% of all breast cancer cases, and the underlying genetic causes and treatment of MBC is not well understood. In a paper published in the March issue…
3 March 2016
NewsEarly MRI screening reduces risk of breast cancer death for survivors of childhood HL
Researchers at Princess Margaret Cancer Centre have confirmed in a screening effectiveness study that early screening with MRIs can reduce breast cancer mortality for female survivors of childhood Hodgkin's lymphoma…
3 March 2016





